Clinical Results

  • Richard N. Fogoros
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 188)


DURING the first 15 years of its clinical use, over 75,000 patients have received the implantable cardioverter defibrillator (ICD). While the concept of an ICD was initially regarded by much of the medical community with great skepticism, the ICD is now seen as one of the most important tools available for preventing death from ventricular tachyarrhythmias. The drastic change in how the ICD is perceived has come directly from the clinical results that have been seen with this device.


Sudden Death Implantable Cardioverter Defibrillator Ventricular Tachyarrhythmia Implantable Cardioverter Defibrillator Therapy Implantable Defibrillator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hurwitz JL, Josephson ME. Sudden cardiac death in patients with chronic coronary artery disease. Circulation 1992;95:143–149.Google Scholar
  2. 2.
    Furukawa T, Rozanski JJ, Nogami A, et al. Time-dependent risk of and predictors for cardiac arrest recurrence in survivors of out-of-hospital cardiac arrest with chronic coronary artery disease. Circulation 1989;80:599–608.PubMedCrossRefGoogle Scholar
  3. 3.
    Fogoros RN, Elson JJ, Bonnet CA, et al. Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testing. J Am Coll Cardiol 1992;19:780–788.PubMedCrossRefGoogle Scholar
  4. 4.
    Wilber JD, Garan H, Finkelstein D, et al. Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988;318:19–24.PubMedCrossRefGoogle Scholar
  5. 5.
    Fogoros RN, Fiedler SB, Elson JJ. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med 1987;107:635–641.PubMedGoogle Scholar
  6. 6.
    Kastor JA. Michel Mirowski and the automatic implantable defibrillator. Am J Cardiol 1989;63:977–982.PubMedCrossRefGoogle Scholar
  7. 7.
    Lown B, Axelrod P. Implanted standby defibrillators. Circulation 1972;46:637–639.PubMedCrossRefGoogle Scholar
  8. 8.
    Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983;98:585–588.PubMedGoogle Scholar
  9. 9.
    Manolis AS, Tan-DeGuzman W, Lee MA, et al. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator. An Heart J 1989;118:445–450.CrossRefGoogle Scholar
  10. 10.
    Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353–1361.PubMedCrossRefGoogle Scholar
  11. 11.
    Thomas AC, Moser SA, Smutka ML, et al. Implantable defibrillation: eight years clinical experience. PACE 1988;11:2053–2058.PubMedCrossRefGoogle Scholar
  12. 12.
    Song SL. The Billitch Report: Performance of implantable cardiac rhythm devices. PACE 1992;15:475–486.PubMedCrossRefGoogle Scholar
  13. 13.
    Lehmann MH, Steinman RT, Schuger CD, et al. The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803–805.PubMedCrossRefGoogle Scholar
  14. 14.
    Akhtar M, Garan H, Lehmann MH, et al. Sudden cardiac death: management of high-risk patients. Ann Intern Med 1991;114:499–512.PubMedGoogle Scholar
  15. 15.
    Powell AC, Fuchs T, Finklestein DM, et al. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083–1092.PubMedCrossRefGoogle Scholar
  16. 16.
    Lessmeier TJ, Lehmann MH, Steinman RT, et al. Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. Am Heart J 1994;128:211–218.PubMedCrossRefGoogle Scholar
  17. 17.
    Lessmeier TJ, Lehmann MH, Steinman RT, et al. Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy of coronary artery disease with myocardial infarction. Am J Cardiol 1993;72:911–915.PubMedCrossRefGoogle Scholar
  18. 18.
    Meissner MD, Lehmann MH, Steinman RT, et al. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 1993;21:1406–1412.PubMedCrossRefGoogle Scholar
  19. 19.
    The PCD investigators group. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy. J Am Coll Cardiol 1994;23:1521–1530.CrossRefGoogle Scholar
  20. 20.
    Böcker D, Block M, Isbruch F, et al. Do patients with implantable defibrillator live longer? J Am Coll Cardiol 1993;21:1638–1644.PubMedCrossRefGoogle Scholar
  21. 21.
    Kleman JM, castle LW, Kidwell GA, et al. Nonthoracotomy versus thoracotomy implantable defibrillators. Intention-to-treat comparison of clinical outcomes. Circulation 1994;90:2833–2842.PubMedCrossRefGoogle Scholar
  22. 22.
    Furman S. AICD benefit. PACE 1989;12:399–400.PubMedCrossRefGoogle Scholar
  23. 23.
    Connolly SJ, Yusuf S. Evaluation of the implantable cardioverter defibrillator in survivors of cardiac arrest: the need for randomized trials. Am J Cardiol 1992;69:959–962.PubMedCrossRefGoogle Scholar
  24. 24.
    Josephson M, Nisam S. Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question? Am J Cardiol 1996;77:859–863.PubMedCrossRefGoogle Scholar
  25. 25.
    Fogoros RN, Elson JJ, Bonnet CA. Survival of patients who have received appropriate shocks from their implantable defibrillators. PACE 1991;14:1842–1845.PubMedCrossRefGoogle Scholar
  26. 26.
    Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 1993;87:1880–1888.PubMedCrossRefGoogle Scholar
  27. 27.
    Tchou PJ, Kadri N, Anderson J, et al. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 1988;109:529–534.PubMedGoogle Scholar
  28. 28.
    Fogoros RN, Elson JJ, Bonnet CA, et al. Efficacy of the automatic implantable cardioverter defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990;16:381–386.PubMedCrossRefGoogle Scholar
  29. 29.
    Grimm W, Marchlinski FE. Shock occurrence and survival in 49 patients with idiopathic dilated cardiomyopathy and an implantable cardioverterdefibrillator. European Heart J 1995;16:218–222.Google Scholar
  30. 30.
    Levine JH, Waller T, Hoch D, et al. Implantable cardioverter defibrillator: use in patients with no symptoms and at high risk. Am Heart J 1996;131:59–65.PubMedCrossRefGoogle Scholar
  31. 31.
    Hamilton RM, Dorian P, Gow RM, et al. Five-year experience with implantable defibrillators in children. Am J Cardiol 1996;77:524–526.PubMedCrossRefGoogle Scholar
  32. 32.
    Newman D, Sauve MJ, Herre J, et al. Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899–903.PubMedCrossRefGoogle Scholar
  33. 33.
    Wever EF, Hauer RNW, van Capelle FJL, et al. Randomized study of implantable defibrillator as first choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995;91:2195–2203.PubMedCrossRefGoogle Scholar
  34. 34.
    Myerburg RJ, Luceri RM, Thurer R, et al. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter defibrillator. J Am Coll Cardiol 1989;14:508–514.PubMedCrossRefGoogle Scholar
  35. 35.
    Veltri EP, Mower MM, Mirowski M, et al. Follow-up of patients with ventricular tachyarrhythmia treated with the automatic implantable cardioverter defibrillator: Programmed electrical stimulation results do not predict clinical outcome. J Electrophysiol 1989;3:467–476.Google Scholar
  36. 36.
    Zipes DP, Roberts D, et al. Results of the international study of the implantable pacemaker cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. Circulation 1995;92:59–65.PubMedCrossRefGoogle Scholar
  37. 37.
    Grimm W, Marchlinski FE. Shock occurrence in patients with an implantable cardioverter-defibrillator without spontaneous shocks before first generator replacement for battery depletion. Am J Cardiol 1994;73:969–970.PubMedCrossRefGoogle Scholar
  38. 38.
    Kim SG, Maloney JD, Pinski SL, et al. Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy. Am J Cardiol 1993;72:1263–1267.PubMedCrossRefGoogle Scholar
  39. 39.
    Akhtar M, Avitall B, Jazayeri M, et al. Role of implantable cardioverter defibrillator therapy in the management of high-risk patients. Circulation 1992;85:1131–1139.Google Scholar
  40. 40.
    Sweeney MO, Ruskin JN, Garan H, et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 1995;92:3273–3281.PubMedCrossRefGoogle Scholar
  41. 41.
    Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New Engl J Med 1996;335:1933–1940.PubMedCrossRefGoogle Scholar
  42. 42.
    Fan W, Peter CT. Survival and incidence of appropriate shocks in implantable cardioverter defibrillator recipients who have no detectable structural heart disease. Am J Cardiol 1994;74:687–690.PubMedCrossRefGoogle Scholar
  43. 43.
    Kelly PA, Cannom DS, Garan H, et al. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988;11:1278–1286.PubMedCrossRefGoogle Scholar
  44. 44.
    Winkle RA, Stinson EB, Echt DS. Practical aspects of automatic cardioverter/defibrillator implantation. Am Heart J 1984;108:1335–1346.PubMedCrossRefGoogle Scholar
  45. 45.
    Mosteller RD, Lehmann MH, Thomas AC, et al. Operative mortality with implantation of the automatic cardioverter-defibrillator. Am J Cardiol 1991;68:1340–1345.PubMedCrossRefGoogle Scholar
  46. 46.
    Kim SG, Fisher JD, Choe CW, et al. Influence of left ventricular function on outcome of patients treated with implantable defibrillators. Circulation 1992;85:1304–1310.PubMedCrossRefGoogle Scholar
  47. 47.
    Veltri EP, Mower MM, Mirowski M, et al. Follow-up of patients with ventricular tachyarrhythmia treated with the automatic implantable cardioverter defibrillator: Programmed electrical stimulation results do not predict clinical outcome. J Electrophysiol 1989;3:467–476.Google Scholar
  48. 48.
    Kim SG, Ling J, Fisher JD, et al. Comparison and frequency of ventricular arrhythmias after defibrillator implantation by thoracotomy versus nonthoracotomy approaches. Am J Cardiol 1994;74:1245–1248.PubMedCrossRefGoogle Scholar
  49. 49.
    Ehrlichb, Endotak Investigators. Early survival and follow-up characteristics of 151 patients undergoing transvenous cardioverter defibrillator lead system implantation. J Am Coll Cardiol 1992;19:209A. (abstract)Google Scholar
  50. 50.
    Shahian DM, Williamson WA, Svensson LG, et al. Transvenous versus transthoracic cardioverter-defibrillator implantation: a comparative analysis of morbidity, mortality, and survival. J Thorac Cardiovasc Surg 1995;109:1066–1074.PubMedCrossRefGoogle Scholar
  51. 51.
    Nunain SO, Roelke M, Trouton T, et al. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 1995;91:2204–2213.PubMedCrossRefGoogle Scholar
  52. 52.
    Luderitz B, Jung W, Deister A, et al. Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am Heart J 1994;127:1179–1184.PubMedCrossRefGoogle Scholar
  53. 53.
    Kalbfleisch KR, Lehmann MH, Steinman RT, et al. Reemployment following implantation of the automatic cardioverter defibrillator. Am J Cardiol 1989;64:199–202PubMedCrossRefGoogle Scholar
  54. 54.
    Veseth-Rogers J. A practical approach to teaching the automatic implantable cardioverter defibrillator patient. J Cardiovasc Nurs 1990;4;7–19.PubMedGoogle Scholar
  55. 55.
    DeBorde R, Aarons D, Biggs M. The automatic implantable cardioverter. AACN Clin Issues Crit Care Nurs 1991;2:170–177.PubMedGoogle Scholar
  56. 56.
    Sneed NV, Finch N. Experience of patients and significant others with automatic implantable cardioverter defibrillators after discharge from the hospital. Prog Cardiovasc Nurs 1992;7:20–24.PubMedGoogle Scholar
  57. 57.
    Vitale MB, Funk M. Quality of life in younger persons with an implantable cardioverter defibrillator. Dim Crit Care Nurs 1995;14:100–111.CrossRefGoogle Scholar
  58. 58.
    Morris PL, Badger J, Chmielewski C, et al. Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics 1991;32:58–64.PubMedCrossRefGoogle Scholar
  59. 59.
    Fricchione GL, Olson LC, Vlay SC. Psychiatric syndromes in patients with the automatic internal cardioverter defibrillator: anxiety, psychological dependence, abuse, and withdrawal. Am Heart J 1989;117:1411–1414.PubMedCrossRefGoogle Scholar
  60. 60.
    May CD, Smith PR, Murdock CJ, et al. The impact of the implantable cardioverter defibrillator on quality-of-life. PACE 1995;18:1411–1418.PubMedCrossRefGoogle Scholar
  61. 61.
    Chevalier P, Verrier P, Kirkorian G, et al. Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator. Psychother Psychosom 1996;65:49–56.PubMedCrossRefGoogle Scholar
  62. 62.
    AVID Investigators. Antiarrhythmics versus implantable defibrillators (AVID)—rationale, design, and methods. Am J Cardiol 1995;75:470–475.CrossRefGoogle Scholar
  63. 63.
    Schöhl W, Trappe H-J, Lichtlen PR. Akzeptanz und lebensqualität nach im-platation eines automatischen Kardioverters/Defibrillators. Z Kardiologie 1994;83:927–932.Google Scholar
  64. 64.
    Ferrans CE, Powers MJ. Psychometric assessment of the quality of life index. Res Nurs Health 1992;15:29–38.PubMedCrossRefGoogle Scholar
  65. 65.
    Bainger EM, Fernsler JI. Perceived quality of life before and after implantation of an internal cardioverter defibrillator. Am J Crit Care 1995;4:36–43.PubMedGoogle Scholar
  66. 66.
    Craney JM, Powers MT. Factors related to driving in persons with an implantable cardioverter defibrillator. Prog Cardiovasc Nurs 1995;10:12–17.PubMedGoogle Scholar
  67. 67.
    Strickberger SA, Cantillon CO, Frieaman PL. When should patients with lethal ventricular arrhythmia resume driving? An analysis of state regulations and ghysician practices. Ann Intern Med 1991;115:560–563.PubMedGoogle Scholar
  68. 68.
    DiCarlo LA, Winston SA, Honoway S, et al. Driving restrictions advised by Midwestern cardiologists implanting cardioverter defibrillators: present practices, criteria utilized, and compatibility with existing state laws. PACE 1992;15:1131–1136.PubMedCrossRefGoogle Scholar
  69. 69.
    Finch NJ, Leman RB, Kratz JM, et al. Driving safety among patients with automatic implantable cardioverter defibrillators. JAMA 1993;270:1587–1588.PubMedCrossRefGoogle Scholar
  70. 70.
    Beauregard LA, Barnard PW, Russo AM, et al. Perceived and actual risks of driving in patients with arrhythmia control devices. Arch Intern Med 1995;155:609–613.PubMedCrossRefGoogle Scholar
  71. 71.
    Anderson MH, Camm AJ. Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator. Am Heart J 1994;127:1185–1193.PubMedCrossRefGoogle Scholar
  72. 72.
    Larsen GC, Stupey MR, Walance CG, et al. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia: implications for driving restrictions. JAMA 1994;271:1335–1339.PubMedCrossRefGoogle Scholar
  73. 73.
    Curtis AB, Conti JB, Tucker KJ, et al. Motor vehicle accidents inpatients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1995;26:180–184.PubMedCrossRefGoogle Scholar
  74. 74.
    Jung W, Lüderitz B. European policy on driving for patients with implantable cardioverter defibrillators. PACE 1996;19:981–984.PubMedCrossRefGoogle Scholar
  75. 75.
    Miles WM, Epstein AE, Benditt DG, et al. Personal and safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. Circulation 1996 (in press) Google Scholar
  76. 76.
    Greene HL. Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study. Am Heart J 1993;127:1171–1178.CrossRefGoogle Scholar
  77. 77.
    Connolly SJ, Jent M, Roberts RS, et al. Canadian Implantation Defibrillator Study (CIDS): study design and organization. Am J Cardiol 1993;72:103F-108F.Google Scholar
  78. 78.
    Siebeis J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the cardiac arrest study Hamburg). Am Heart J 1994;127:1139–1144.CrossRefGoogle Scholar
  79. 79.
    Bigger JT. Future studies with the implantable cardioverter defibrillator. PACE 1991;14:883–889.PubMedCrossRefGoogle Scholar
  80. 80.
    Fogoros RN. An AVID dissent. PACE 1994;17:1707–1711.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Richard N. Fogoros

There are no affiliations available

Personalised recommendations